GENE AND VACCINE THERAPY
Participants working together on gene and vaccine therapy include:
|
William Wierda, M.D., Ph.D., Working Group Chair
University of Texas MD Anderson Cancer Center |
|
Peter Hillmen, M.D., Ph.D.
Pinderfields Hospital (United Kingdom) |
|
Thomas Kipps, M.D., Ph.D.
University of California, San Diego
Rebecca and John Moores Cancer Center |
|
Håkan Mellstedt, M.D., Ph.D.
Karolinska University Hospital (Sweden) |
|
Anders Österborg, M.D.
Karolinska University Hospital (Sweden) |
|
Andy Rawstron, Ph.D.
Leeds Teaching Hospitals NHS Trust (United Kingdom) |
|
Clemens Wendtner, M.D.
University of Cologne (Germany) |
|
Projects Funded
Gene Therapy with ISF-35 Transduced Autologous CLL Cell Vaccine
William Wierda, M.D., Ph.D.
CLL Vaccines
Thomas Kipps, M.D., Ph.D.
The tyrosine kinase receptor ROR1 - a potential target for Mab Therapy
of CLL
Håkan Mellstedt, M.D., Ph.D.
Identification and validation of potential targets for the diagnosis and therapy of CLL
Andy Rawstron, Ph.D.
Evaluation of antigen-specific immune responses in the context of
gene-modified tumor cell vaccines for CLL
Clemens-Martin Wendtner, M.D.
|
